As of 2023, Japan imported approximately 78.75 thousand kilograms of Phenazone (Antipyrin). From 2024 onward, forecast data predict a steady increase in imports, reaching 81.16 thousand kilograms by 2028. The year-on-year growth is marginal, consistently around 0.62%. The five-year compound annual growth rate (CAGR) stands at approximately 0.60%, suggesting a stable but slow upward trend in import volumes.
Future trends to watch for include:
- Potential shifts in pharmaceutical demand that could influence import needs.
- Regulatory changes impacting drug imports within Japan.
- Global supply chain dynamics affecting raw material availability and pricing.
